Literature DB >> 3559662

Radiation therapy for brain metastases.

G E Sheline, L W Brady.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3559662     DOI： 10.1007/BF00150613

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  7 in total

1.  Radiation therapy for intracranial metastatic neoplasia.

Authors:  L W Brady; E L Mancall; D K Lee; L B Neff; A T Shockman; D S Faust; J Antoniades; S Prasasvinichai; R J Torpie; J R Glassburn
Journal:  Radiol Clin Biol       Date:  1974

2.  The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group.

Authors:  B Borgelt; R Gelber; S Kramer; L W Brady; C H Chang; L W Davis; C A Perez; F R Hendrickson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-01       Impact factor: 7.038

3.  Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group.

Authors:  B Borgelt; R Gelber; M Larson; F Hendrickson; T Griffin; R Roth
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-12       Impact factor: 7.038

4.  The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group.

Authors:  J M Kurtz; R Gelber; L W Brady; R J Carella; J S Cooper
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-07       Impact factor: 7.038

5.  The influence of surgery and radiation therapy on patients with brain metastases.

Authors:  F R Hendrickson; M S Lee; M Larson; R D Gelber
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-05       Impact factor: 7.038

6.  Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis.

Authors:  R D Gelber; M Larson; B B Borgelt; S Kramer
Journal:  Cancer       Date:  1981-10-15       Impact factor: 6.860

7.  Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: Radiation Therapy Oncology Group Brain Metastases Study I and II.

Authors:  R J Carella; R Gelber; F Hendrickson; H C Berry; J S Cooper
Journal:  Cancer       Date:  1980-02-15       Impact factor: 6.860
  7 in total
  5 in total

1.  The prognostic factors of lung cancer patients with brain metastases treated with radiotherapy.

Authors:  C Y Hsiung; S W Leung; C J Wang; S K Lo; H C Chen; L M Sun; F M Fang
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

2.  Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.

Authors:  A Gabriella Wernicke; Menachem Z Yondorf; Luke Peng; Samuel Trichter; Lucy Nedialkova; Albert Sabbas; Fridon Kulidzhanov; Bhupesh Parashar; Dattatreyudu Nori; K S Clifford Chao; Paul Christos; Ilhami Kovanlikaya; Susan Pannullo; John A Boockvar; Philip E Stieg; Theodore H Schwartz
Journal:  J Neurosurg       Date:  2014-05-02       Impact factor: 5.115

3.  Single Brain Metastasis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2001-01       Impact factor: 3.598

4.  Phase II study of lonidamine plus radiotherapy in the treatment of brain metastases.

Authors:  D J Stewart; L Eapen; A Girard; S Verma; P Genest; W K Evans
Journal:  J Neurooncol       Date:  1993-01       Impact factor: 4.130

5.  Surgical resection and permanent iodine-125 brachytherapy for brain metastases.

Authors:  Kim Huang; Penny K Sneed; Sandeep Kunwar; Annemarie Kragten; David A Larson; Mitchel S Berger; Albert Chan; Jean Pouliot; Michael W McDermott
Journal:  J Neurooncol       Date:  2008-08-22       Impact factor: 4.130
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.